Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Embryonic testis differentiation homolog B (ETDB, also referred to as LINC00633) is a gene identified with the HGNC symbol ETDB (HGNC:44269) and located on human chromosome 11. It is mainly classified as a long intergenic noncoding RNA (lincRNA), indicating that it is not predicted to encode a functional protein. Despite alternative names suggesting a protein-coding function, major reference sources such as GeneCards and the Human Protein Atlas list both protein and non-protein coding aliases but offer no experimental evidence for molecular function, biological process, or disease involvement. There are no reported interactions with drugs, no clinical biomarker applications, and no established roles as a therapeutic target. Its principal aliases derive from its genomic annotation history; at times it has been listed as a noncoding RNA (LINC00633) and other times as a hypothetical protein homolog, which has led to confusion in nomenclature. There is no evidence supporting its consideration as a “therapeutic target” (such as a receptor, enzyme, transporter, or signaling protein typically modulated by drugs). Most available references emphasize the lack of functional and disease annotation and suggest that its name reflects annotation rather than experimentally validated function. If you require canonical information for downstream analysis, treat this entry as a likely noncoding RNA (not a bona fide protein or druggable target) until and unless future research defines a functional, disease, or pharmacological significance.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Embryonic testis differentiation homolog B (ETDB).